Iris BioTechnologies Chairman & CEO Simon Chin Gave Acceptance Speech for Frost & Sullivan's 2008 North America Technology Innovation Award in Pharmacogenomics

SANTA CLARA, Calif.--(BUSINESS WIRE)--Simon Chin, founder, chairman, & CEO of Iris BioTechnologies (OTCBB: IRSB), a theranostics company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, gave his acceptance speech for Frost & Sullivan’s 2008 North American Technology Innovation Award in the field of Pharmacogenomics at the Growth Excellence Awards Banquet. The event was held Monday, September 15th at the Park 55 Hotel in San Francisco, CA.